Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 401–427 of 427 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06646211	High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)	not yet recruiting	Phase 2	30	Sun Yat-sen UniversityOTHER	1	Oct 17, 2024	clinicaltrials
NCT04070040	Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL)	recruiting	Phase 2	21	Beijing Sanbo Brain HospitalOTHER	1	Oct 15, 2024	clinicaltrials